FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Delayed Deutsche Boerse AG 03:50:18 2024-06-03 pm EDT | ||
| 9.51 EUR | 0.00% |
|
| 1 month | +7.58% | ||
| 3 months | +45.41% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-06-03 | 9.51 | 0.00% |
| 24-05-31 | 9.51 | +3.71% |
| 24-05-30 | 9.17 | +2.80% |
| 24-05-29 | 8.92 | -2.19% |
| 24-05-28 | 9.12 | -3.80% |
Delayed Quote Deutsche Boerse AG
Last update June 03, 2024 at 03:50 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PG4QDG |
| ISIN | DE000PG4QDG3 |
| Date issued | 2023-11-07 |
| Strike | 142 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.75 € |
|---|---|
| Lowest since issue | 5.89 € |
| Spread | 0.23 € |
| Spread % | 2.35% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.1
USD
Average target price
147
USD
Spread / Average Target
+4.17%
- Stock Market
- Certificates
- Certificat
